Skip to main content
Livermore
Livermore
ZHEN

Gibson Christopher's Form 4/A amendment

Amended

Recursion Pharmaceuticals, Inc. (RXRX) · filed Apr 28, 2023

Accession no.
0001209191-23-026045
Filed
Apr 28, 2023
Trade date
Jan 5-Dec 14, 2022
Filing delay
478 days
Rule 10b5-1 plan
Not checked
Original filed
Jan 6, 2023

This filing lists 22 non-derivative transactions and 11 derivative transactions. Open-market sales total $136.7K. It was filed 478 days after the trade.

This amendment replaces 0001209191-23-002460 (filed Jan 6, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gibson ChristopherCIK 0001856369Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 25, 2022Class A Common StockCConversionAcquired+12,000$0.00$0594,805Direct
Apr 25, 2022Class A Common StockGGiftDisposed−12,000$0.00$0582,805Direct
May 12, 2022Class A Common StockCConversionAcquired+12,000$0.00$0594,805Direct
May 12, 2022Class A Common StockGGiftDisposed−12,000$0.00$0582,805Direct
May 19, 2022Class A Common StockCConversionAcquired+12,000$0.00$0594,805Direct
May 19, 2022Class A Common StockGGiftDisposed−12,000$0.00$0582,805Direct
Jun 21, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Jun 21, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Jul 19, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Jul 19, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Aug 17, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Aug 17, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Sep 19, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Sep 19, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Oct 19, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Oct 19, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Nov 16, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Nov 16, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Dec 14, 2022Class A Common StockCConversionAcquired+3,000$0.00$0585,805Direct
Dec 14, 2022Class A Common StockGGiftDisposed−3,000$0.00$0582,805Direct
Jan 5, 2022Class A Common StockCConversionAcquired+18,500$0.00$0601,305Direct
Jan 5, 2022Class A Common StockSSaleDisposed−18,500$7.39F5−$136,715582,805Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 25, 2022Class A Common StockCConversionDisposed−12,000$0.00$06,665,334Direct
May 12, 2022Class A Common StockCConversionDisposed−12,000$0.00$06,653,334Direct
May 19, 2022Class A Common StockCConversionDisposed−12,000$0.00$06,641,334Direct
Jun 21, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,638,334Direct
Jul 19, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,635,334Direct
Aug 17, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,632,334Direct
Sep 19, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,629,334Direct
Oct 19, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,626,334Direct
Nov 16, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,623,334Direct
Dec 14, 2022Class A Common StockCConversionDisposed−3,000$0.00$06,620,334Direct
Jan 5, 2022Class A Common StockCConversionDisposed−18,500$0.00$06,601,834Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2

The sole purpose of this amended Form 4 is to correctly reflect that the shares gifted between April 25, 2022 and December 14, 2022 were first converted from the Reporting Person's holdings of Class B common stock.

F3

Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person.

F4

Represents the conversion of Class B Common Stock into Class A Common Stock.

F5

This transaction was executed in multiple trades at prices ranging from $7.29 to $7.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F6

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

Read the full filing on SEC EDGAR (opens in a new tab)